MAPT and Alzheimer disease: In relation to AD, numerous research using cellular and rodent models has shown that vitamin D relieves AD pathology by reducing Aβ accumulation through decreasing Aβ formation and increasing its degradation and by inhibiting tau phosphorylation accompanied by prolific cellular changes reducing neuronal loss, oxidative stress and neuroinflammation [88,89].